All In MedTech

Device Trial Radar · NCT07938112

Efficacy and Safety of Electroacupuncture in the Treatment of Esophageal Symptoms in Non-erosive Reflux Disease (NERD) Patients

Investigating the Efficacy and Safety of Electroacupuncture in the Treatment of Esophageal Symptoms in Non-erosive Reflux Disease (NERD) Patients: A Pilot, Randomized Double-blinded, Sham-controlled Trial

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

96

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Dec 2027

Study completion Mar 2028

Sponsor

Lead sponsor
Nanyang Technological UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National University Hospital, Singapore
First posted
Nov 16, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 21 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if acupuncture works to treat non-erosive reflux disease (NERD) patients. The main questions it aims to answer are: 1. Electroacupuncture (EA) is superior to sham EA in terms of easing the symptom severity of NERD. 2. Acupuncture is able to influence gastrointestinal function, autonomic regulation, and stress responses in NERD patients. Participants will: 1. Receive acupuncture treatment twice per week for 6 weeks. 2. Leave plasma, serum, saliva, stool, and urine samples at baseline, mid-treatment, and end-of-treatment. 3. Complete patient-reported-outcomes (PROs) at baseline, mid-treatment, and end-of-treatment

Conditions

  • Non-erosive Reflux Disease (NERD)

Interventions

  • Acupuncture needlesDevice

    The acupuncture needles and related equipment will have already received approval for routine Traditional Chinese Medicine (TCM) clinical practice in Singapore.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Gastroesophageal Reflux Disease Questionnaire (GERDQ)Time frame: From enrollment to the end of follow-up at 16 weeks
  2. Gastrointestinal Symptom Rating scale (GSRS)Time frame: From enrollment to the end of follow-up at 16 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nanyang Technological University, School of Biological Sciences

    Singapore, Singapore

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.